An operation and a technology are different interventions
Robotic colorectal surgery has a credible technical rationale and an expanding clinical evidence base. That does not make every proposed advantage a demonstrated patient benefit. The evidence is most informative when separated by operation, outcome, surgeon experience and platform. Rectal dissection in a narrow pelvis is a different technical problem from routine right colectomy. A result from one setting should not quietly become a claim about all colorectal surgery.
This narrative review distinguishes established findings from plausible mechanisms and unresolved questions. By October 2026, it is no longer accurate to say that randomised evidence shows no oncological advantage anywhere: the REAL trial reported better locoregional control in its studied population. It is equally inaccurate to describe robotic surgery as universally superior. The proper conclusion remains conditional on the patients, teams and methods actually evaluated.
Why the technical rationale is persuasive
Wristed instruments, a stable magnified view and surgeon-controlled camera movement may make dissection and suturing easier in confined spaces. The console may reduce some of the physical demands of long procedures. These features have particular appeal during low pelvic dissection, where instrument crowding and limited angles can complicate conventional laparoscopy. They provide a coherent explanation for why a benefit might exist.
However, technical convenience and clinical effectiveness require different measurements. A comfortable surgeon may still have an anastomotic leak. A well-demonstrated nerve plane does not establish preserved sexual function months later. The bedside assistant, docking process, instrument availability and response to haemorrhage remain part of the operation. A platform should therefore be evaluated as part of an operating system involving people and processes, rather than as an isolated machine.
